BioInsights - Pandemic-related supply chain disruptions in cell therapy require rapid qualification for single-sourced materials

Pandemic-related supply chain disruptions in cell therapy require rapid qualification for single-sourced materials

Cell & Gene Therapy Insights 2022; 8(2), 257–260

10.18609/cgti.2022.042

Published: 7 March 2022
Viewpoint
John Duguid, Paul Friedman